Europeans OK Amgen’s Kyprolis for multiple myeloma treatment
European regulators approved Amgen’s potential blockbuster drug Kyprolis on July 4 as a treatment for multiple myeloma. The European Commission approved a treatment of Kyprolis and dexamethasone in patients who’ve received at least one previous multiple myeloma treatment. In November, the commission approved a Kyprolis treatment using lenalidomide and dexamethasone for patients who’ve received at Read More →
LTC Properties announces monthly dividend of 18 cents per share
Westlake Village-based LTC Properties has declared a monthly cash dividend on its common stock for the third quarter of 2016. The dividend will be 18 cents per common share per month for July, August and September 2016, payable on July 29, Aug. 31 and Sept. 30, 2016, respectively, to stockholders of record on July 21, Read More →
Inphi sells memory product business for $90 million
Inphi sold its memory product business to Rambus for $90 million in cash June 30. The Santa Clara-based company, which designs chips aimed at packing more memory onto Internet servers and increasing bandwidth, employs a large engineering force in Thousand Oaks. The sale will allow it to focus on its communications business, Inphi said in Read More →
Hill: Planning for a post-Diablo Canyon future
By Adam Hill As the news of the deal that will close Diablo Canyon continues to reverberate through our community, it’s critical that we begin to plan now for our post-Diablo future. We simply can’t afford to be apathetic or to behave like a broken-hearted lover bemoaning co-dependency. This is perhaps the best test yet Read More →
Sohn: Brexit will drag down global economy
By Sung Won Sohn The global financial tsunami has begun. The United Kingdom’s vote to split from the European Union marks the first divorce in EU history, so there is no precedent to estimate the magnitude of economic pain in store for the U.K., the EU or the rest of the world. Most likely it Read More →